durapatite has been researched along with warfarin in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delmas, PD; Guillaumont, M; Leclercq, M; Plantalech, L; Vergnaud, P | 1 |
| Price, PA | 1 |
| Bajpai, PK; Mileti, IF | 1 |
| Banks, RE; Callahan, BC; Cook, SD; Dalton, JE; Lisecki, EJ; Wolff, JD | 1 |
| Guenthner, TM; Wallin, R | 1 |
| Cai, D; Guenthner, TM; Wallin, R | 1 |
| Bajpai, PK; Lasserre, A; Szmulowicz, U; Tarr, ER | 1 |
| Abrams, S; Gundberg, CM; Nieman, SD; Rosen, H | 1 |
| Blanchette, J; Bouvet, C; de Blois, D; Moreau, P; Moreau, S | 1 |
| Lomashvili, KA; O'Neill, WC; Wallin, R; Wang, X | 1 |
| Chen, P; Li, Y; Liu, X; Meng, L; Sun, J; Yu, X; Zhu, Y | 1 |
| Won, SJ; Woo, SH | 1 |
| Deng, X; Dong, P; Liu, Y; Ma, J; Sun, X; Zhang, Y; Zhu, D | 1 |
1 review(s) available for durapatite and warfarin
| Article | Year |
|---|---|
Vitamin K-dependent formation of bone Gla protein (osteocalcin) and its function.
Topics: Amino Acid Sequence; Animals; Bone and Bones; Bone Diseases, Metabolic; Calcitriol; Calcium-Binding Proteins; Chemotactic Factors; Durapatite; Growth Plate; Humans; Hydroxyapatites; Osteocalcin; Vitamin K; Warfarin | 1985 |
12 other study(ies) available for durapatite and warfarin
| Article | Year |
|---|---|
Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women.
Topics: Adult; Aged; Aged, 80 and over; Aging; Durapatite; Female; Humans; Hydroxyapatites; Middle Aged; Osteocalcin; Radioimmunoassay; Vitamin K; Vitamin K 1; Warfarin | 1991 |
Development of a hydroxyapatite ceramic matrix for the continuous delivery of coumadin.
Topics: Ceramics; Drug Delivery Systems; Durapatite; Humans; In Vitro Techniques; Pressure; Warfarin | 1995 |
The effect of warfarin on the attachment of bone to hydroxyapatite-coated and uncoated porous implants.
Topics: Analysis of Variance; Animals; Chromium Alloys; Durapatite; Female; Femur; Goats; Osseointegration; Porosity; Prostheses and Implants; Stress, Mechanical; Surface Properties; Warfarin | 1995 |
Purification of warfarin-sensitive vitamin K epoxide reductase.
Topics: Animals; Antibodies; Chromatography; Chromatography, Gel; Durapatite; Kinetics; Microsomes; Mixed Function Oxygenases; Molecular Weight; Phospholipases A; Vitamin K Epoxide Reductases; Warfarin | 1997 |
Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
Topics: Animals; Chromatography; Chromatography, Gel; Cross Reactions; Durapatite; Electrophoresis, Polyacrylamide Gel; Epoxide Hydrolases; Immune Sera; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Molecular Weight; Rats; Vitamin K Epoxide Reductases; Warfarin | 1998 |
A hydroxyapatite system for the continuous release of coumadin an anticoagulant.
Topics: Animals; Anticoagulants; Biocompatible Materials; Blood Coagulation; Ceramics; Dose-Response Relationship, Drug; Drug Implants; Durapatite; Rats; Rats, Sprague-Dawley; Warfarin | 1997 |
Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin.
Topics: Adult; Antibodies, Monoclonal; Anticoagulants; Barium Sulfate; Child; Durapatite; False Positive Reactions; Humans; Nutritional Status; Osteocalcin; Peptide Fragments; Quality Control; Radioimmunoassay; Reagent Kits, Diagnostic; Vitamin K; Warfarin | 1998 |
Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis.
Topics: Animals; Aorta, Abdominal; Calcinosis; Collagen; Disease Models, Animal; Durapatite; Elastin; Femoral Artery; Male; Matrix Metalloproteinase 9; Osteopontin; Rats; Rats, Wistar; Signal Transduction; Transforming Growth Factor beta; Vascular Diseases; Warfarin | 2008 |
Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification.
Topics: Animals; Anticoagulants; Aorta; Bone Morphogenetic Protein 2; Calcinosis; Calcium-Binding Proteins; Core Binding Factor Alpha 1 Subunit; Durapatite; Extracellular Matrix Proteins; Male; Matrix Gla Protein; Models, Biological; Muscle, Smooth, Vascular; Organ Culture Techniques; Osteogenesis; Protein Binding; Rats; Rats, Sprague-Dawley; Renal Insufficiency; RNA, Messenger; Up-Regulation; Uremia; Warfarin | 2011 |
Corrosion resistance of biodegradable Mg with a composite polymer coating.
Topics: Animals; Coated Materials, Biocompatible; Corrosion; Coumarins; Durapatite; Magnesium; Male; Nanoparticles; Polyglutamic Acid; Prostheses and Implants; Rabbits | 2016 |
Calcium Hydroxylapatite Pulmonary Embolism after Percutaneous Injection Laryngoplasty.
Topics: Biocompatible Materials; Durapatite; Female; Humans; Injections, Intralesional; Laryngoplasty; Middle Aged; Postoperative Complications; Pulmonary Embolism; Tomography, X-Ray Computed; Treatment Outcome; Vocal Cord Paralysis; Warfarin | 2017 |
Effect of hydroxyapatite nanoparticles and wedelolactone on osteoblastogenesis from bone marrow mesenchymal stem cells.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Coumarins; Durapatite; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Osteoblasts | 2019 |